348 related articles for article (PubMed ID: 21707691)
21. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
[TBL] [Abstract][Full Text] [Related]
22. Lack of mitogenic activity of speG- and speG(dys)-positive Streptococcus dysgalactiae subspecies equisimilis isolates from patients with invasive infections.
Brandt CM; Schweizer KG; Holland R; Lütticken R; Freyaldenhoven BS
Int J Med Microbiol; 2005 Dec; 295(8):539-46. PubMed ID: 16325550
[TBL] [Abstract][Full Text] [Related]
23. Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study.
Ekelund K; Darenberg J; Norrby-Teglund A; Hoffmann S; Bang D; Skinhøj P; Konradsen HB
J Clin Microbiol; 2005 Jul; 43(7):3101-9. PubMed ID: 16000420
[TBL] [Abstract][Full Text] [Related]
24. Species-dependent post-translational modification and position 2 allelism: effects on streptococcal superantigen SSA structure and V beta specificity.
Stevens KR; Van M; Lamphear JG; Orkiszewski RS; Ballard KD; Cook RG; Rich RR
J Immunol; 1996 Sep; 157(6):2479-87. PubMed ID: 8805648
[TBL] [Abstract][Full Text] [Related]
25. Comparison of emm typing and ribotyping with three restriction enzymes to characterize clinical isolates of Streptococcus pyogenes.
Doktor SZ; Beyer JM; Flamm RK; Shortridge VD
J Clin Microbiol; 2005 Jan; 43(1):150-5. PubMed ID: 15634964
[TBL] [Abstract][Full Text] [Related]
26. Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes.
Kittang BR; Bruun T; Langeland N; Mylvaganam H; Glambek M; Skrede S
Clin Microbiol Infect; 2011 Mar; 17(3):358-64. PubMed ID: 20456456
[TBL] [Abstract][Full Text] [Related]
27. A new closed-tube multiplex real-time PCR to detect eleven superantigens of Streptococcus pyogenes identifies a strain without superantigen activity.
Lintges M; Arlt S; Uciechowski P; Plümäkers B; Reinert RR; Al-Lahham A; Lütticken R; Rink L
Int J Med Microbiol; 2007 Oct; 297(6):471-8. PubMed ID: 17481952
[TBL] [Abstract][Full Text] [Related]
28. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002.
Shulman ST; Tanz RR; Kabat W; Kabat K; Cederlund E; Patel D; Li Z; Sakota V; Dale JB; Beall B;
Clin Infect Dis; 2004 Aug; 39(3):325-32. PubMed ID: 15306998
[TBL] [Abstract][Full Text] [Related]
29. Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates.
Schmitz FJ; Beyer A; Charpentier E; Normark BH; Schade M; Fluit AC; Hafner D; Novak R
J Infect Dis; 2003 Nov; 188(10):1578-86. PubMed ID: 14624385
[TBL] [Abstract][Full Text] [Related]
30. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.
Alouf JE; Müller-Alouf H
Int J Med Microbiol; 2003 Feb; 292(7-8):429-40. PubMed ID: 12635926
[TBL] [Abstract][Full Text] [Related]
31. M-protein gene-type distribution and hyaluronic acid capsule in group A Streptococcus clinical isolates in Chile: association of emm gene markers with csrR alleles.
Wozniak A; Rojas P; Rodríguez C; Undabarrena A; Garate C; Riedel I; Román JC; Kalergis AM; García P
Epidemiol Infect; 2012 Jul; 140(7):1286-95. PubMed ID: 21906413
[TBL] [Abstract][Full Text] [Related]
32. Group A streptococcal genotypes from pediatric throat isolates in Rome, Italy.
Dicuonzo G; Gherardi G; Lorino G; Angeletti S; De Cesaris M; Fiscarelli E; Bessen DE; Beall B
J Clin Microbiol; 2001 May; 39(5):1687-90. PubMed ID: 11325974
[TBL] [Abstract][Full Text] [Related]
33. Distribution of emm genotypes and superantigen genes of Streptococcus pyogenes isolated in Japan, 1994-9.
Murakami J; Kawabata S; Terao Y; Kikuchi K; Totsuka K; Tamaru A; Katsukawa C; Moriya K; Nakagawa I; Morisaki I; Hamada S
Epidemiol Infect; 2002 Jun; 128(3):397-404. PubMed ID: 12113483
[TBL] [Abstract][Full Text] [Related]
34. [Distribution of emm genotypes and antibiotic susceptibility of Streptococcus pyogenes strains: analogy with the vaccine in development].
Arslan U; Oryaşın E; Eskin Z; Türk Dağı H; Fındık D; Tuncer I; Bozdoğan B
Mikrobiyol Bul; 2013 Apr; 47(2):318-23. PubMed ID: 23621731
[TBL] [Abstract][Full Text] [Related]
35. Streptococcus pyogenes emm and T types within a decade, 1996-2005: implications for epidemiology and future vaccines.
Nir-Paz R; Korenman Z; Ron M; Michael-Gayego A; Cohen-Poradosu R; Valinsky L; Beall B; Moses AE
Epidemiol Infect; 2010 Jan; 138(1):53-60. PubMed ID: 19480723
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiological investigation of an outbreak of invasive beta-haemolytic streptococcal infection in western Norway.
Mylvaganam H; Bruun T; Vindenes HA; Langeland N; Skrede S
Clin Microbiol Infect; 2009 Mar; 15(3):245-52. PubMed ID: 19178544
[TBL] [Abstract][Full Text] [Related]
37. The bacterial superantigen and superantigen-like proteins.
Fraser JD; Proft T
Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
[TBL] [Abstract][Full Text] [Related]
38. Nosocomial transmission of invasive group a streptococcus from patient to health care worker.
Lacy MD; Horn K
Clin Infect Dis; 2009 Aug; 49(3):354-7. PubMed ID: 19580415
[TBL] [Abstract][Full Text] [Related]
39. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
Shulman ST; Tanz RR; Dale JB; Beall B; Kabat W; Kabat K; Cederlund E; Patel D; Rippe J; Li Z; Sakota V;
Clin Infect Dis; 2009 Jul; 49(1):78-84. PubMed ID: 19480575
[TBL] [Abstract][Full Text] [Related]
40. Distribution of streptococcal inhibitor of complement variants in pharyngitis and invasive isolates in an epidemic of serotype M1 group A Streptococcus infection.
Hoe NP; Vuopio-Varkila J; Vaara M; Grigsby D; De Lorenzo D; Fu YX; Dou SJ; Pan X; Nakashima K; Musser JM
J Infect Dis; 2001 Feb; 183(4):633-9. PubMed ID: 11170990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
